Bausch + Lomb Corp
NYSE:BLCO

Watchlist Manager
Bausch + Lomb Corp Logo
Bausch + Lomb Corp
NYSE:BLCO
Watchlist
Price: 11.47 USD -2.13% Market Closed
Market Cap: 4.1B USD

Profitability Summary

Bausch + Lomb Corp's profitability score is 46/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

46/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

46/100
Profitability
Score
46/100
Profitability
Score

Past Growth

Analyzing past growth in Revenue, Operating Income, and Net Income allows investors to assess the company's profitability and operational efficiency. Consistent improvement in these metrics typically signals long-term strength and stability.

Show More Less

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Show More Less

Earnings Waterfall
Bausch + Lomb Corp

Revenue
4.8B USD
Cost of Revenue
-1.9B USD
Gross Profit
2.9B USD
Operating Expenses
-2.8B USD
Operating Income
127m USD
Other Expenses
-489m USD
Net Income
-362m USD

Margins Comparison
Bausch + Lomb Corp Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
CA
Bausch + Lomb Corp
NYSE:BLCO
4.1B USD
60%
3%
-8%
CH
Alcon AG
SIX:ALC
35B CHF
54%
14%
11%
JP
Hoya Corp
TSE:7741
5.9T JPY
86%
29%
23%
DK
Coloplast A/S
CSE:COLO B
143.2B DKK
68%
27%
16%
US
Align Technology Inc
NASDAQ:ALGN
13.2B USD
70%
16%
10%
UK
ConvaTec Group PLC
LSE:CTEC
5.9B GBP
57%
15%
8%
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
47.1B CNY
70%
43%
40%
CH
Ypsomed Holding AG
SIX:YPSN
5.5B CHF
39%
15%
12%
US
Merit Medical Systems Inc
NASDAQ:MMSI
5.6B USD
48%
12%
9%
KR
HLB Inc
KOSDAQ:028300
7.2T KRW
20%
-149%
-253%
US
Lantheus Holdings Inc
NASDAQ:LNTH
5.2B USD
64%
29%
17%

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Show More Less

Return on Capital Comparison
Bausch + Lomb Corp Competitors

Country Company Market Cap ROE ROA ROCE ROIC
CA
Bausch + Lomb Corp
NYSE:BLCO
4.1B USD
-6%
-3%
1%
1%
CH
Alcon AG
SIX:ALC
35B CHF
5%
4%
5%
4%
JP
Hoya Corp
TSE:7741
5.9T JPY
21%
17%
24%
32%
DK
Coloplast A/S
CSE:COLO B
143.2B DKK
27%
9%
22%
11%
US
Align Technology Inc
NASDAQ:ALGN
13.2B USD
11%
7%
16%
9%
UK
ConvaTec Group PLC
LSE:CTEC
5.9B GBP
11%
5%
11%
9%
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
47.1B CNY
17%
16%
19%
24%
CH
Ypsomed Holding AG
SIX:YPSN
5.5B CHF
13%
7%
15%
8%
US
Merit Medical Systems Inc
NASDAQ:MMSI
5.6B USD
9%
5%
7%
7%
KR
HLB Inc
KOSDAQ:028300
7.2T KRW
-34%
-22%
-16%
-15%
US
Lantheus Holdings Inc
NASDAQ:LNTH
5.2B USD
24%
13%
26%
30%

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

Show More Less